Clinical value of rheumatoid factor and anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis

Gui-zhi XING,Li-ming MA,Yuan AN

2014-01-01

Abstract:Objective To investigate the clinical value of rheumatoid factor(RF)and anti-cyclic citrullinated peptide antibody(anti-CCP antibody)in the diagnosis of rheumatoid arthritis(RA).Methods The RF and anti-CCP antibody results of 87 cases of RA,34 cases of systemic lupus erythematosus(SLE),29 cases of mixed connective tissue disease (MCTD),21 cases of Sjogren's syndrome(SS)were analyzed retrospectively,and the RF was measured by immunotur-bidimetry,while the anti-CCP antibody was by enzyme linked immunosorbent assay(ELISA).Results ①RF and anti-CCP antibody test results RA patients were higher than the other three groups of patients,the differences were statisti-cally significant(P <0.05).②For diagnosis of RA,the RF had a sensitivity of 86.2%,specificity of 72.6%,positive <br> predictive value(PPV)of 76.5%,negative predictive value(NPV)of 83.6%,and overall accuracy of 79.5%.③For di-agnosis of RA,the anti-CCP antibody had a sensitivity of 81.6%,specificity of 85.7%,PPV of 85.5%,NPV of 81.8%,and overall accuracy of 83.6% in the diagnosis of RA.④The RF and anti-CCP antibody by serial method had a sensitivity of 79.3%,specificity of 94.0%,PPV of 93.2%,NPV of 81.4%,and overall accuracy of 86.5% in the diag-nosis of RA.Conclusion The RF and anti-CCP antibody by serial method is able to improve the specificity in the diag-nosis of RA,so this way contributes to differential diagnosis of RA and other autoimmune diseases.